Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
0.3044
-0.0009 (-0.29%)
May 16, 2025, 10:28 AM - Market open

Ovid Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
0.550.570.391.5208.3812.62
Upgrade
Revenue Growth (YoY)
15.61%44.39%-73.91%-99.28%1551.57%-
Upgrade
Gross Profit
0.550.570.391.5208.3812.62
Upgrade
Selling, General & Admin
22.7423.8829.5932.4337.2330.63
Upgrade
Research & Development
31.3335.0728.3924.6246.9463.42
Upgrade
Operating Expenses
54.0758.9557.9757.0584.1794.05
Upgrade
Operating Income
-53.52-58.39-57.58-55.55124.21-81.43
Upgrade
Interest & Investment Income
-----0.4
Upgrade
Other Non Operating Income (Expenses)
31.9332.14.941.83-0.05-
Upgrade
EBT Excluding Unusual Items
-22.42-26.28-52.64-53.71124.16-81.04
Upgrade
Merger & Restructuring Charges
-3.5-3.5-1.7---
Upgrade
Gain (Loss) on Sale of Investments
-0.853.352-0.45--
Upgrade
Pretax Income
-24.97-26.43-52.34-54.17124.16-81.04
Upgrade
Income Tax Expense
----1.33-
Upgrade
Net Income
-24.97-26.43-52.34-54.17122.83-81.04
Upgrade
Preferred Dividends & Other Adjustments
-0.64-0.46-0.91-3-
Upgrade
Net Income to Common
-24.34-25.98-51.43-54.17119.84-81.04
Upgrade
Shares Outstanding (Basic)
717171706758
Upgrade
Shares Outstanding (Diluted)
717171706858
Upgrade
Shares Change (YoY)
0.50%0.46%0.22%3.46%16.45%49.05%
Upgrade
EPS (Basic)
-0.34-0.37-0.73-0.771.78-1.39
Upgrade
EPS (Diluted)
-0.34-0.37-0.73-0.771.76-1.39
Upgrade
Free Cash Flow
-49.6-56.03-45.82-56.45118.43-51.71
Upgrade
Free Cash Flow Per Share
-0.70-0.79-0.65-0.801.74-0.89
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-9766.06%-10315.37%-14689.03%-3696.44%59.61%-645.40%
Upgrade
Profit Margin
-4441.42%-4589.22%-13119.39%-3604.66%57.51%-642.26%
Upgrade
Free Cash Flow Margin
-9051.46%-9898.76%-11689.03%-3756.55%56.83%-409.85%
Upgrade
EBITDA
-52.9-57.77-57.01-55.04124.45-81.12
Upgrade
EBITDA Margin
----59.72%-
Upgrade
D&A For EBITDA
0.620.610.570.510.240.31
Upgrade
EBIT
-53.52-58.39-57.58-55.55124.21-81.43
Upgrade
EBIT Margin
----59.61%-
Upgrade
Effective Tax Rate
----1.07%-
Upgrade
Revenue as Reported
0.550.570.391.5208.3812.62
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q